A23V2250/204

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTEROL GALLSTONE COMPRISING URSODEOXYCHOLIC ACID (UDCA) AND OMEGA-3 FATTY ACID, AND PROCESS FOR PRODUCING THE SAME
20200376003 · 2020-12-03 ·

The present invention relates to a gallstone solubilizing agent, comprising ursodeoxycholic acid (UDCA) or a pharmaceutically acceptable salt thereof; omega-3 fatty acid; and an excipient, the gallstone solubilizing agent resulting in a process which prevents cholesterol gallstones from being formed or causes cholesterol gallstones to be dissolved, a pharmaceutical composition comprising the same, and a health functional food composition comprising the same. A pharmaceutical composition prepared to have UDCA and omega-3 fatty acid at an optimal content ratio allows cholesterol to remain in a dissolved state without forming crystals, and thus results in a process which prevents cholesterol gallstones from being formed or causes cholesterol gallstones to be dissolved, thereby exhibiting increased effects of preventing or treating cholesterol gallstones.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTEROL GALLSTONE COMPRISING URSODEOXYCHOLIC ACID (UDCA) AND OMEGA-3 FATTY ACID, AND PROCESS FOR PRODUCING THE SAME
20200376003 · 2020-12-03 ·

The present invention relates to a gallstone solubilizing agent, comprising ursodeoxycholic acid (UDCA) or a pharmaceutically acceptable salt thereof; omega-3 fatty acid; and an excipient, the gallstone solubilizing agent resulting in a process which prevents cholesterol gallstones from being formed or causes cholesterol gallstones to be dissolved, a pharmaceutical composition comprising the same, and a health functional food composition comprising the same. A pharmaceutical composition prepared to have UDCA and omega-3 fatty acid at an optimal content ratio allows cholesterol to remain in a dissolved state without forming crystals, and thus results in a process which prevents cholesterol gallstones from being formed or causes cholesterol gallstones to be dissolved, thereby exhibiting increased effects of preventing or treating cholesterol gallstones.

METHOD FOR PRODUCING HONEY CONTAINING LOW MOLECULAR WEIGHT GINSENOSIDES
20200359669 · 2020-11-19 · ·

A method for producing honey containing low molecular weight ginsenosides, includes steps of: washing ginseng; damaging epidermis of the ginseng; mixing the ginseng whose epidermis is damaged with honey to form a first mixture; heating the first mixture in a thermal bath; cooling the heated first mixture; separating the heated and cooled first mixture into honey and ginseng; cooling the separated ginseng to 0 C. to 6 C. and cooling the separated honey at room temperature, each cooled for 10 to 24 hours; mixing the cooled ginseng and honey again to form a second mixture; aging the second mixture at a low temperature; separating the low-temperature-aged second mixture into ginseng and honey; and aging the honey separated from the second mixture at a low temperature at least 12 hours.

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PROTECTING JOINTS, METHOD FOR PRODUCING THE SAME AND USE THEREOF

The present invention relates to the field of health care food technology, specifically to a traditional Chinese medicine composition with a function of protecting joints, a use thereof, a method for producing the same and a health care food thereof. The Chinese medicine composition comprises CURCUMAE LONGAE RHIZOMA extract, cartilage extract, COICIS SEMEN extract and PUERARIAE LOBATAE RADIX extract. The composition of the present disclosure has a reasonable formulation, and the ingredients cooperate with each other to achieve functions of reducing arthrocele degree, decreasing arthritis index, ameliorating biochemical index of arthritis and reducing articular cavity area through various paths and at various levels.

GENOME STABILITY ENHANCER

Disclosed is a genome stability enhancer comprising, as an active ingredient, at least one member selected from the group consisting of enzymatically degraded royal jelly, gnetum or its extract, and gnetin C.

GENOME STABILITY ENHANCER

Disclosed is a genome stability enhancer comprising, as an active ingredient, at least one member selected from the group consisting of enzymatically degraded royal jelly, gnetum or its extract, and gnetin C.

Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-

Extracts or beverages whose ratio between the content of 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S)-(unit: g/100 g) and Brix (Bx) is 6 (g/100 g)/Bx or more are good in flavor and feeling on the tongue and further have a good appearance.

Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-

Extracts or beverages whose ratio between the content of 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S)-(unit: g/100 g) and Brix (Bx) is 6 (g/100 g)/Bx or more are good in flavor and feeling on the tongue and further have a good appearance.

Six-Kingdom Oral Nutritional Supplement Composition
20190239550 · 2019-08-08 · ·

The invention is a nutritional composition in unit dosage form for oral administration to an animal or human, which includes at least one ingredient from each of six biological Kingdoms selected from the group consisting of animals, plants, fungi, bacteria, protist and archaea. Each ingredient is co-admixed with every other said ingredient without further addition of synthetic excipients or fillers, and is typically formulated in dried powder form as a drink mix, food or beverage additive or as the fill for hard or soft capsules or other dosage forms including tablets (the compositions of the invention can generally be tableted without addition of ingredients beyond the nutrients themselves).

Six-Kingdom Oral Nutritional Supplement Composition
20190239550 · 2019-08-08 · ·

The invention is a nutritional composition in unit dosage form for oral administration to an animal or human, which includes at least one ingredient from each of six biological Kingdoms selected from the group consisting of animals, plants, fungi, bacteria, protist and archaea. Each ingredient is co-admixed with every other said ingredient without further addition of synthetic excipients or fillers, and is typically formulated in dried powder form as a drink mix, food or beverage additive or as the fill for hard or soft capsules or other dosage forms including tablets (the compositions of the invention can generally be tableted without addition of ingredients beyond the nutrients themselves).